Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03741777 · ClinicalTrials.gov registry record · NA
Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
A NA study of Fasting and Gastric Emptying, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 288
- Enrollment target
- 1
- Study location
NCT03741777: Recruiting NA study of Fasting and Gastric Emptying, sponsored by Boston Children's Hospital.
NCT03741777 is a NA study of Fasting and Gastric Emptying that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 288 participants, above the 174-participant average among 8 other Fasting trials with a reported enrollment target (66% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03741777, a NA study of Fasting and Gastric Emptying, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
- 1
- Study location
Study Summary
According to the American Society of Anesthesiologists (ASA) fasting guideline for patients undergoing elective surgery, the 2-hour fasting period is suggested for clear oral fluid (including water, pulp-free juice and tea or coffee without milk). This guideline does not give any suggestions for proper volume of clear oral fluid intake. This study is a prospective randomized control trials in children aged 13 through 17 years who are scheduled for an elective upper GI endoscopy procedure in the Gastroenteral Procedure Unit (GPU) at Boston Children's Hospital. The participants will be randomly assigned into one of four groups: Group 1 will consume 3 ml/kg of clear fluid by mouth at 2-hour period before surgical scheduled time, Group 2 will consume 5 ml/kg, Group 3 will consume 7 ml/kg, and Group 4 will consume 10 ml/kg. The investigators plan to recruit 72 patients in each group and 288 patients for the whole study. Research team will collect patient's demographic data, vital signs, information about their EGD procedure. Then actual volume of the stomach content and acidity will be measured from the content that is suctioned from patient's stomach during upper GI endoscopy procedure. The investigators believe that the information from this study will help establish a comprehensive NPO guideline.
Primary Outcome
Actual gastric content volume (ml) suctioned out of each pediatric patient's stomach
Conditions Studied
Interventions
- OTHER Clear oral fluid
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2024-02-29 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT03741777 shows while recruiting
NCT03741777 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, above the 174-participant average among 8 other Fasting trials with a reported enrollment target (66% higher).
The record links to 2 conditions, with Fasting appearing as the primary indexed condition, and to 1 intervention - of which Clear oral fluid is the first listed.
NCT03741777 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03741777 about?
NCT03741777 is a clinical study titled "Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume". According to the American Society of Anesthesiologists (ASA) fasting guideline for patients undergoing elective surgery, the 2-hour fasting period is suggested for clear oral fluid (including water, pulp-free juice and tea or coffee without milk). This guideline does not give any suggestions for pro...
What is the current status of trial NCT03741777?
This trial is currently recruiting. It is a NA study. The enrollment target is 288 participants. The study started on 2024-02-29. Estimated completion is 2025-12.
What conditions does trial NCT03741777 study?
This clinical trial studies the following conditions: Fasting, Gastric Emptying.
What interventions are being tested in trial NCT03741777?
The interventions under investigation include: Clear oral fluid (OTHER).
Who is sponsoring clinical trial NCT03741777?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03741777 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fasting
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03741777's enrollment target sits among peer trials
288 2nd of 8 the highest of 8 other Fasting trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fasting trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
-
Immunomodulatory Effects of Fasting in Healthy Adults
RECRUITING · NA
-
Effect of Fasting on Patient Outcomes After Wide-Awake, Local Anesthesia-only, No Tourniquet (WALANT) Procedures
RECRUITING · NA
-
Regulation of FGF21 by Nutritional Challenges
COMPLETED · NA
-
Gastric Assessment of Pediatric Patients Undergoing Surgery
RECRUITING
-
Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
- NCT03937635 · 288 participants · Phase 3
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- NCT04621877 · 288 participants · NA
Lay-Delivered Behavioral Activation in Senior Centers
- NCT05150704 · 288 participants · Phase 3
MYTHS - MYocarditis THerapy With Steroids
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI